Bangladesh’s Second-Largest Drug Maker Gets Major U.S. Investment
This article was originally published in PharmAsia News
Executive Summary
A U.S.-based equity firm has agreed to invest $67 million in Beximco Pharmaceutical, the second-largest drug maker in Bangladesh. The investment also is the largest by a foreign firm in the nation's pharmaceutical industry. The GEM Global Yield Fund dollars are expected to help Beximco increase production and exports. The company's vice chairman said the decision was a reflection of the confidence foreign investors have in Bangladesh. (Click here for more